Skip to content

Clinical trials

Phase 4 Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 4 Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20055
20061
20072
20085
20091
20104
20112
20123
20132
20144
20152
20164
20171
20181
20191
20213
20243
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Withdrawn5
Terminated4
Unknown status3
Not yet recruiting3
Recruiting2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
KU Leuven2
Qing-Lei Zeng2
Queen's University2
Sanofi2
Watson Pharmaceuticals2
Zhujiang Hospital2
A. D. Struthers1
Amgen1
Apkar Apkarian1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome53
Pain5
Disease4
Low Back Pain4
Renal Insufficiency4
Renal Insufficiency, Chronic4
Anemia3
Hepatitis B3
Hepatitis B, Chronic3
Neuralgia3

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.